Buy or sell: Sumeet Bagadia recommends 3 stocks to buy on Monday - 17 February 2025
The Nifty 50 index has fallen for eight consecutive sessions, dropping 3.4% amid trade war concerns. Sumeet Bagadia ...
Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Crexendo's Bullish Run: Capitalizing On Microsoft's Exit And Cloud Demand
As shown, with Crexendo’s levered FCF margin of 13.2% and its current WACC, the stock still has ample upside potential.
Applied Materials Earnings: Chip Investment Driving Good Results Despite China Headwind
Applied Materials' AMAT January-quarter sales rose 7% year over year and 2% sequentially to $7.17 billion. April-quarter ...
Stock Market Highlights: Nifty faces bearish reversal after 8th straight loss
A long bear candle was formed on the weekly chart, which indicates a reversal on the downside after the two weeks of upside ...
The Financial Express1d
Eleganz Interiors Share Price
Check Eleganz Interiors Stock Price live NSE/BSE on financialexpress.com. Get Eleganz Interiors today's stock price, 52-week high, 52-week low, Eleganz Interiors quarterly results, share performance, ...
Stocks To Buy On Valentine’s Day: Intraday BUY/SELL Calls By Sumeet Bagadia On Friday, 14th Feb
Choice Broking executive director Sumeet Bagadia recommended purchasing two stocks on Valentines Day, following the formation ...
BioArctic AB: Interim Report for the period October - December 2024
Pioneering license agreement with BrainTransporter signed with BMS worth up to USD 1.35 billion plus royalties Events during the fourth quarter 2024 The Australian Medicines Agency (TGA) decided not ...
Emera Inc. stock rises Thursday, still underperforms market
Emera Inc. closed 0.7% below its 52-week high of C$56.33, which the company achieved on February 3rd.
Trade Spotlight: How should you trade Bajaj Finserv, Muthoot Finance, SBI Card, UPL, Cholamandalam Investment, Redington, and others on February 14?
While the market may rebound amid consolidation, sustaining the expected recovery is key to watch. Below are some trading ...
How To Navigate Volatile Markets
Hotter inflation numbers and rising yields increases investor uncertainty and market volatility. The Viper Report’s Tom ...
Egetis Therapeutics AB: European Commission approves Egetis' Emcitate (tiratricol) as the first and only treatment for patients with MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...